These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11906071)

  • 21. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).
    Upton SJ; Tilley M; Nesterenko MV; Brillhart DB
    FEMS Microbiol Lett; 1994 May; 118(1-2):45-9. PubMed ID: 8013881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological characterization of Cryptosporidium parvum life-cycle stages in an in vitro model system.
    Borowski H; Thompson RC; Armstrong T; Clode PL
    Parasitology; 2010 Jan; 137(1):13-26. PubMed ID: 19691870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viability of Cryptosporidium parvum oocysts in natural waters.
    Brasseur P; Uguen C; Moreno-Sabater A; Favennec L; Ballet JJ
    Folia Parasitol (Praha); 1998; 45(2):113-6. PubMed ID: 9684321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic acid stains as indicators of Cryptosporidium parvum oocyst viability.
    Belosevic M; Guy RA; Taghi-Kilani R; Neumann NF; Gyürék LL; Liyanage LR; Millard PJ; Finch GR
    Int J Parasitol; 1997 Jul; 27(7):787-98. PubMed ID: 9279581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental dispersal of Cryptosporidium parvum oocysts and cross transmission in cultured bivalve molluscs.
    Gómez-Couso H; Freire-Santos F; Ortega-Iñarrea MR; Castro-Hermida JA; Ares-Mazás ME
    Parasitol Res; 2003 Jun; 90(2):140-2. PubMed ID: 12756549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts.
    Quilez J; Sanchez-Acedo C; Avendaño C; del Cacho E; Lopez-Bernad F
    Appl Environ Microbiol; 2005 May; 71(5):2479-83. PubMed ID: 15870337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1997 Aug; 83(4):771-4. PubMed ID: 9267429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An improved electron microscopic technique for the immunolabeling of Cryptosporidium parvum oocysts.
    Jenkins MC; Murphy C; Trout J; Fayer R
    J Parasitol; 2006 Apr; 92(2):403-5. PubMed ID: 16729705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological changes and viability of Cryptosporidium parvum sporozoites after excystation in cell-free culture media.
    Matsubayashi M; Ando H; Kimata I; Nakagawa H; Furuya M; Tani H; Sasai K
    Parasitology; 2010 Nov; 137(13):1861-6. PubMed ID: 20800015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of Cryptosporidium parvum in anaerobic digesters treating manure by (reverse-transcription) quantitative real-time PCR, infectivity and excystation tests.
    Garcés G; Effenberger M; Najdrowski M; Wackwitz C; Gronauer A; Wilderer PA; Lebuhn M
    Water Sci Technol; 2006; 53(8):195-202. PubMed ID: 16784204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of high-rate algal ponds on viability of Cryptosporidium parvum oocysts.
    Araki S; Martín-Gomez S; Bécares E; De Luis-Calabuig E; Rojo-Vazquez F
    Appl Environ Microbiol; 2001 Jul; 67(7):3322-4. PubMed ID: 11425762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of Cryptosporidium parvum under chlorinated recreational water conditions.
    Shields JM; Hill VR; Arrowood MJ; Beach MJ
    J Water Health; 2008 Dec; 6(4):513-20. PubMed ID: 18401116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of tests for viable and infectious Cryptosporidium parvum oocysts.
    Jenkins M; Trout JM; Higgins J; Dorsch M; Veal D; Fayer R
    Parasitol Res; 2003 Jan; 89(1):1-5. PubMed ID: 12474036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization processes.
    Barbee SL; Weber DJ; Sobsey MD; Rutala WA
    Gastrointest Endosc; 1999 May; 49(5):605-11. PubMed ID: 10228259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts.
    Delling C; Lendner M; Müller U; Daugschies A
    Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of glutaraldehyde disinfectant against Cryptosporidium parvum in the presence of various organic soils.
    Wilson J; Margolin AB
    J AOAC Int; 2003; 86(1):96-100. PubMed ID: 12607746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of disinfectant concentration and pH in the inactivation kinetics of Cryptosporidium parvum oocysts with ozone and monochloramine.
    Rennecker JL; Kim JH; Corona-Vasquez B; Mariñas BJ
    Environ Sci Technol; 2001 Jul; 35(13):2752-7. PubMed ID: 11452604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry based assay to determine the effects of treatments on Cryptosporidium parvum viability.
    Phelps KK; Lindsay DS; Sumner SS; Fayer R
    J Eukaryot Microbiol; 2001; Suppl():40S-41S. PubMed ID: 11906073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.